What Elife Sciences does

eLife Sciences (legal entity: eLife Sciences Publications, Ltd) is a 501(c)(3) nonprofit open-access publisher focused on life sciences and biomedical research. Founded in 2011/2012 and headquartered in Cambridge, UK, the organization operates the eLife Journal, which since January 2023 publishes papers under a "Reviewed Preprints" model: every paper that completes peer review is published alongside public peer reviews and an eLife Assessment summarizing significance (landmark to useful) and strength of evidence (exceptional to inadequate), eliminating the traditional accept/reject outcome after review. The catalog spans 19 subject areas including Cell Biology, Neuroscience, Immunology, and Evolutionary Biology, with content licensed under CC-BY 4.0 and made freely available globally without paywall or registration. Adjacent offerings include the eLife Podcast (e.g., Episode 103, May 2026), a YouTube channel, active Bluesky and Threads presences, and public APIs.

Underlying technology consists of a digital publishing platform with HTML/PDF article rendering, a full XML article corpus distributed via GitHub, open-source publishing software products under permissive licensing, and developer-facing APIs that expose article metadata, peer reviews, and assessments. The architecture is built around open standards (CC-BY 4.0, XML, public APIs) and is designed for adoption by other scholarly publishing initiatives, not just internal use.

The business model is institutional funding rather than transactional revenue. eLife charges no publication fees to authors and no access or subscription fees to readers. Operations are sustained by a coalition of four major biomedical research funders — Howard Hughes Medical Institute (HHMI), Wellcome Trust, Max Planck Society, and the Knut and Alice Wallenberg Foundation — with a disclosed "significant" Wellcome Trust grant in March 2026 earmarked for building an open publishing ecosystem and collaborative publishing tools. The organization employs 51–100 staff, serves a global community of academic researchers, science journalists, and institutional readers, and pursues go-to-market through community-led engagement (academic networks, conferences, editorial reputation) and event-driven media outreach (press releases, podcast episodes).

Name

Elife Sciences

Legal name

eLife Sciences Publications, Ltd

Website

https://elifesciences.org

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

eLife Sciences is a nonprofit open-access publisher of life sciences and biomedical research, funded by HHMI, Wellcome, Max Planck, and Wallenberg Foundation, serving global academic researchers through a reviewed-preprints model with public peer reviews.

Ownership category

akta.pro rank

Product category

Open-Access Scientific Publishing

NAICS

Book Publishers (513130)

SIC

Books: Publishing Or Publishing & Printing (2731)

akta.pro primary industry

Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing (EDAGAFAC)

Keywords

• Open access publishing
• Scientific peer review
• Biomedical journal
• Research preprints
• Scholarly publishing platform

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Non-profit Organization Funding: eLife Sciences Publications, Ltd is a 501(c)(3) nonprofit organization funded by major research funders. The organization does not charge publication fees to authors and provides open access to all published content free of charge to readers.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

Elife Sciences is a nonprofit open-access publisher that operates the eLife Journal, publishing peer-reviewed life sciences and biomedical research articles under a CC-BY 4.0 license. Its core, differentiating service is the Reviewed Preprints model in which papers that complete peer review are published as preprints with public peer reviews and structured eLife Assessments (rating significance and strength of evidence), rather than being accepted or rejected after review. The organization charges no publication fees to authors and no subscription or access fees to readers, and distributes content via its website, open APIs, and an XML corpus on GitHub.

Product overview

eLife Sciences operates a comprehensive open-access publishing platform for life sciences and biomedical research. The core offering consists of the eLife Journal, which publishes research articles alongside Reviewed Preprints with public peer reviews and eLife assessments. The organization has introduced a new publishing model that ends the traditional accept-reject decision, instead publishing reviewed preprints with open peer review. Additional offerings include the eLife Podcast, open-source software tools available on GitHub, and the full XML article corpus for research data access. All content is published under Creative Commons Attribution (CC-BY 4.0) license.

Differentiator

Problem solved

Functional benefit

Products and services

• eLife Journal Flagship open-access journal for life sciences and biomedical research that publishes peer-reviewed research articles, insights, feature articles, and editorials under CC-BY 4.0 with no publication or access fees. Targeted at researchers, students, clinicians, and the broader scientific community across 19 subject areas.
• eLife Reviewed Preprints Peer-reviewed preprints that have completed eLife's review process and are published with full public peer reviews and an eLife Assessment summarizing significance and strength of evidence, instead of being accepted or rejected. Targeted at life sciences and biomedical researchers seeking rapid open dissemination with transparent peer review.
• eLife Podcast Regular podcast episodes (e.g., Episode 103 in May 2026) featuring discussions of scientific research published in eLife and conversations with researchers and editors. Targeted at the scientific community and science-interested general audience.
• eLife Open Source Software Products Suite of open-source publishing software products developed by eLife and published on its GitHub organization under permissive open-source licenses, intended for adoption by other publishers and the scholarly community to accelerate discovery and transform research communication.
• eLife Article XML Corpus Full corpus of eLife scientific manuscripts published as articles, distributed in XML format for download from the eLife GitHub repository (elife-article-xml) and licensed under CC-BY 4.0, enabling text mining, computational analysis, and reuse by researchers and developers.

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Springer Nature: Major legacy publisher of Nature and hundreds of other journals, including open-access titles. Comparable as a broad incumbent in scientific publishing whose portfolio overlaps significantly with eLife's life sciences scope.
• Cell Press (Elsevier): Publisher of Cell and related life sciences journals under Elsevier. Comparable as a broad incumbent publishing peer-reviewed life sciences and biomedical research.
• AAAS (publisher of Science): Publisher of Science and Science family journals. Comparable as a broad incumbent in scientific publishing competing for the same high-prestige life sciences submissions.

Direct peers

• F1000Research: Open-access publishing platform using post-publication peer review. Comparable as an open-access, transparent-review model serving life sciences researchers.
• PeerJ: Open-access peer-reviewed publisher in the life sciences and medicine, with a member-fee business model. Directly comparable in audience (life sciences researchers) and open-access publishing model.
• BioMed Central: Large open-access publisher of peer-reviewed life sciences journals, part of Springer Nature. Directly comparable in offering open-access publishing in life sciences and biomedicine.
• Hindawi: Open-access academic publisher (now part of Wiley) covering sciences including life sciences. Comparable as an open-access journal publisher serving similar researcher authors.
• bioRxiv and medRxiv: Preprint servers operated by Cold Spring Harbor Laboratory for life sciences and clinical research. Comparable because they serve the same researcher audience with rapid, open research sharing, and intersect with eLife's preprint-friendly model.
• PLOS (Public Library of Science): Nonprofit open-access publisher of peer-reviewed scientific journals across life sciences and medicine. Most direct comparable to eLife given shared nonprofit, open-access, no-fee or low-fee model and similar scientific audience.
• Wellcome Open Research: Open-access publishing platform funded by Wellcome Trust using post-publication peer review. Highly comparable given shared Wellcome funding, open-access model, and life sciences focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• GitHubgithub.com/elifesciences
• YouTubeyoutube.com/channel/UCNEHLtAc_JPI84xW8V4XWyw
• Xx.com/elife
• Facebookfacebook.com/elifesciences
• LinkedInlinkedin.com/company/elife-sciences-publications-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elife Sciences